Thomas Flaten
Stock Analyst at Lake Street
(0.97)
# 2,739
Out of 4,479 analysts
29
Total ratings
31.82%
Success rate
-17.35%
Average return
Main Sectors:
13 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| OPTN OptiNose | Maintains: Buy | $4 → $3 | $1.04 | +188.46% | 3 | May 15, 2024 | |
| PSNL Personalis | Initiates: Buy | $4 | $1.20 | +233.33% | 1 | Apr 30, 2024 | |
| ASRT Assertio Holdings | Maintains: Buy | $4 → $3 | $1.15 | +160.87% | 3 | Mar 12, 2024 | |
| AQST Aquestive Therapeutics | Maintains: Buy | $3 → $8 | $2.42 | +230.58% | 1 | Mar 7, 2024 | |
| ACHV Achieve Life Sciences | Maintains: Buy | $19 → $11 | $4.59 | +139.65% | 3 | Mar 5, 2024 | |
| CKPT Checkpoint Therapeutics | Maintains: Buy | $16 → $14 | $2.13 | +557.28% | 3 | Aug 16, 2023 | |
| BTTX Better Therapeutics | Maintains: Buy | $5 → $3 | $0.01 | +22,976.92% | 2 | Aug 10, 2023 | |
| BLFS BioLife Solutions | Maintains: Buy | $34 → $25 | $20.23 | +23.58% | 2 | Aug 9, 2023 | |
| CSTL Castle Biosciences | Reiterates: Buy | $32 | $21.26 | +50.52% | 4 | Jul 7, 2023 | |
| EVAX Evaxion Biotech | Maintains: Buy | $180 → $70 | $2.90 | +2,317.96% | 1 | Mar 31, 2023 | |
| OCX OncoCyte | Downgrades: Hold | $60 → $10 | $2.96 | +237.84% | 3 | Dec 1, 2022 | |
| ENSC Ensysce Biosciences | Maintains: Buy | $960 → $96 | $0.48 | +20,097.77% | 2 | Nov 17, 2022 | |
| DMAC DiaMedica Therapeutics | Maintains: Buy | $14 → $8 | $2.80 | +185.71% | 1 | Jul 7, 2022 |
OptiNose
May 15, 2024
Maintains: Buy
Price Target: $4 → $3
Current: $1.04
Upside: +188.46%
Personalis
Apr 30, 2024
Initiates: Buy
Price Target: $4
Current: $1.20
Upside: +233.33%
Assertio Holdings
Mar 12, 2024
Maintains: Buy
Price Target: $4 → $3
Current: $1.15
Upside: +160.87%
Aquestive Therapeutics
Mar 7, 2024
Maintains: Buy
Price Target: $3 → $8
Current: $2.42
Upside: +230.58%
Achieve Life Sciences
Mar 5, 2024
Maintains: Buy
Price Target: $19 → $11
Current: $4.59
Upside: +139.65%
Checkpoint Therapeutics
Aug 16, 2023
Maintains: Buy
Price Target: $16 → $14
Current: $2.13
Upside: +557.28%
Better Therapeutics
Aug 10, 2023
Maintains: Buy
Price Target: $5 → $3
Current: $0.01
Upside: +22,976.92%
BioLife Solutions
Aug 9, 2023
Maintains: Buy
Price Target: $34 → $25
Current: $20.23
Upside: +23.58%
Castle Biosciences
Jul 7, 2023
Reiterates: Buy
Price Target: $32
Current: $21.26
Upside: +50.52%
Evaxion Biotech
Mar 31, 2023
Maintains: Buy
Price Target: $180 → $70
Current: $2.90
Upside: +2,317.96%
OncoCyte
Dec 1, 2022
Downgrades: Hold
Price Target: $60 → $10
Current: $2.96
Upside: +237.84%
Ensysce Biosciences
Nov 17, 2022
Maintains: Buy
Price Target: $960 → $96
Current: $0.48
Upside: +20,097.77%
DiaMedica Therapeutics
Jul 7, 2022
Maintains: Buy
Price Target: $14 → $8
Current: $2.80
Upside: +185.71%